These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

715 related articles for article (PubMed ID: 23159314)

  • 1. Anti-inflammatory properties rather than anti-oxidant capability is the major mechanism of neuroprotection by sodium salicylate in a chronic rotenone model of Parkinson's disease.
    Thakur P; Nehru B
    Neuroscience; 2013 Feb; 231():420-31. PubMed ID: 23159314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effects of vildagliptin in rat rotenone Parkinson's disease model: role of RAGE-NFκB and Nrf2-antioxidant signaling pathways.
    Abdelsalam RM; Safar MM
    J Neurochem; 2015 Jun; 133(5):700-7. PubMed ID: 25752913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
    Saravanan KS; Sindhu KM; Senthilkumar KS; Mohanakumar KP
    Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models.
    Hu LF; Lu M; Tiong CX; Dawe GS; Hu G; Bian JS
    Aging Cell; 2010 Apr; 9(2):135-46. PubMed ID: 20041858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulatory effects of sodium salicylate on the factors affecting protein aggregation during rotenone induced Parkinson's disease pathology.
    Thakur P; Nehru B
    Neurochem Int; 2014 Sep; 75():1-10. PubMed ID: 24852355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective potential of ferulic acid in the rotenone model of Parkinson's disease.
    Ojha S; Javed H; Azimullah S; Abul Khair SB; Haque ME
    Drug Des Devel Ther; 2015; 9():5499-510. PubMed ID: 26504373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effect of agmatine (decarboxylated l-arginine) against oxidative stress and neuroinflammation in rotenone model of Parkinson's disease.
    El-Sayed EK; Ahmed A; Morsy EE; Nofal S
    Hum Exp Toxicol; 2019 Feb; 38(2):173-184. PubMed ID: 30001633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycyrrhizic acid Attenuates Neuroinflammation and Oxidative Stress in Rotenone Model of Parkinson's Disease.
    Ojha S; Javed H; Azimullah S; Abul Khair SB; Haque ME
    Neurotox Res; 2016 Feb; 29(2):275-87. PubMed ID: 26607911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral alterations in rotenone model of Parkinson's disease: attenuation by co-treatment of centrophenoxine.
    Nehru B; Verma R; Khanna P; Sharma SK
    Brain Res; 2008 Mar; 1201():122-7. PubMed ID: 18308296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease.
    Chung YC; Kim SR; Jin BK
    J Immunol; 2010 Jul; 185(2):1230-7. PubMed ID: 20566832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease.
    Verma R; Nehru B
    Neurochem Int; 2009 Nov; 55(6):369-75. PubMed ID: 19375462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effect of nerolidol against neuroinflammation and oxidative stress induced by rotenone.
    Javed H; Azimullah S; Abul Khair SB; Ojha S; Haque ME
    BMC Neurosci; 2016 Aug; 17(1):58. PubMed ID: 27549180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetramethylpyrazine Ameliorates Rotenone-Induced Parkinson's Disease in Rats: Involvement of Its Anti-Inflammatory and Anti-Apoptotic Actions.
    Michel HE; Tadros MG; Esmat A; Khalifa AE; Abdel-Tawab AM
    Mol Neurobiol; 2017 Sep; 54(7):4866-4878. PubMed ID: 27514753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Caryophyllene, a phytocannabinoid attenuates oxidative stress, neuroinflammation, glial activation, and salvages dopaminergic neurons in a rat model of Parkinson disease.
    Ojha S; Javed H; Azimullah S; Haque ME
    Mol Cell Biochem; 2016 Jul; 418(1-2):59-70. PubMed ID: 27316720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolongifolene mitigates rotenone-induced dopamine depletion and motor deficits through anti-oxidative and anti-apoptotic effects in a rat model of Parkinson's disease.
    Balakrishnan R; Vijayraja D; Mohankumar T; Manimaran D; Ganesan P; Choi DK; Elangovan N
    J Chem Neuroanat; 2021 Mar; 112():101890. PubMed ID: 33220427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ameliorative effect of Sida cordifolia in rotenone induced oxidative stress model of Parkinson's disease.
    Khurana N; Gajbhiye A
    Neurotoxicology; 2013 Dec; 39():57-64. PubMed ID: 23994302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium salicylate protects against rotenone-induced parkinsonism in rats.
    Madathil SK; Karuppagounder SS; Mohanakumar KP
    Synapse; 2013 Aug; 67(8):502-14. PubMed ID: 23447126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures.
    Testa CM; Sherer TB; Greenamyre JT
    Brain Res Mol Brain Res; 2005 Mar; 134(1):109-18. PubMed ID: 15790535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease.
    Zbarsky V; Datla KP; Parkar S; Rai DK; Aruoma OI; Dexter DT
    Free Radic Res; 2005 Oct; 39(10):1119-25. PubMed ID: 16298737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of pioglitazone and retinoic acid in a rotenone model of Parkinson's disease.
    Ulusoy GK; Celik T; Kayir H; Gürsoy M; Isik AT; Uzbay TI
    Brain Res Bull; 2011 Jul; 85(6):380-4. PubMed ID: 21600965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.